List of works - Charles A Peloquin

A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment

scientific article published on 07 October 2019

Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model.

scientific article published on 26 November 2018

Activity of the Fluoroquinolone DC-159a in the Initial and Continuation Phases of Treatment of Murine Tuberculosis ⬇️

scientific article published on January 31, 2011

Antituberculosis therapy for 2012 and beyond ⬇️

scientific article published on February 15, 2012

Building optimal 3-drug combination chemotherapy regimens

scientific article published on 08 September 2020

Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype

scientific article published in 2022

Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis ⬇️

scientific article published on July 1, 2013

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis

scientific article published on 25 April 2019

Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans

scientific article published on 23 September 2019

Developing new drugs for the therapy of Mycobacterium tuberculosis: What information do we get from pre-clinical animal models?

scientific article published on 21 September 2020

Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions

scientific article published on 17 February 2020

Editorial Commentary: Pharmacokinetic Variability and Tuberculosis Treatment Outcomes, Including Acquired Drug Resistance ⬇️

scientific article published on March 30, 2012

Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old

scientific article published on 23 September 2019

Effect of Grapefruit Juice on Clarithromycin Pharmacokinetics ⬇️

scientific article published on April 1, 1998

Effect of rifampin/isoniazid-containing antituberculosis therapy on efavirenz pharmacokinetics in HIV-infected children aged 3 to 14 years old

article

Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations.

scientific article published on 27 August 2018

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection

scientific article published on 24 June 2019

Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis

scientific article published on 24 September 2018

Levofloxacin for Drug-Resistant Mycobacterium Tuberculosis ⬇️

scientific article published on 01 February 1998

Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients

scientific article published on 24 June 2019

Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model

scientific article published on 27 July 2018

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis

scientific article published on 01 December 2018

Oral Cimetidine Prolongs Clarithromycin Absorption ⬇️

scientific article published on July 1, 1998

PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis ⬇️

scientific article published on October 11, 2010

Pharmacokinetic Mismatch of Tuberculosis Drugs ⬇️

scientific article published on March 1, 2012

Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis

scientific article published on 25 April 2019

Pharmacokinetics of para-Aminosalicylic Acid Granules under Four Dosing Conditions ⬇️

scientific article published on November 1, 2001

Pharmacometrics in Dose Finding or Dose Optimization of Anti-Retroviral and Anti-Tubercular Drugs ⬇️

scientific article published on April 1, 2011

Poor Absorption of High-Dose Posaconazole in Pediatric Bone Marrow Transplant Patients ⬇️

scientific article published on 07 August 2012

Population pharmacokinetic model and limited sampling strategies for personalized dosing of levofloxacin in tuberculosis patients

scientific article published on 26 November 2018

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide ⬇️

scientific article published on December 1, 1997

Population pharmacokinetics and target attainment of cefepime in critically ill patients and guidance for initial dosing

scientific article published on 29 June 2020

Posaconazole Pharmacokinetics in a 2‐Year‐Old Boy with Rhino‐Cerebral‐Orbital Zygomycosis ⬇️

scientific article published on January 1, 2013

Prediction and In Vitro Evaluation of Selected Protease Inhibitor Antiviral Drugs as Inhibitors of Carboxylesterase 1: A Potential Source of Drug-Drug Interactions ⬇️

scientific article published on 09 December 2011

Protein Binding of First-Line Antituberculous Drugs.

scientific article

Reply to “Contradictory Results with High-Dosage Rifamycin in Mice and Humans” ⬇️

scientific article published on February 1, 2013

Rifampin Stability ⬇️

scientific article published on 01 August 1998

Serum Concentrations of the Antimycobacterial Drugs ⬇️

scientific article published on 01 May 1998

Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis ⬇️

scientific article published on April 2, 2012

Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis ⬇️

scientific article published on September 19, 2011

The Funnel: A screening technique for identifying optimal two-drug combination chemotherapy regimens

scientific article published on 16 November 2020

The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections

scientific article published on July 1, 1997

The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters ⬇️

scientific article published on August 6, 2010

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

scientific article published on 01 November 2019

Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice ⬇️

scientific article published on February 17, 2011

Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series

scientific article published on 13 April 2020

Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial

scientific article published on 04 October 2019

List of works by Charles A Peloquin